Arch Therapeutics, Inc.
http://www.archtherapeutics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Arch Therapeutics, Inc.
Deals Shaping The Medical Industry, March 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in February 2017.
Arch Therapeutics Closes In On CE Mark For Novel Blood Control Agent
Securing the CE mark for its topical hemostatic agent has taken Arch Therapeutics longer than expected, but the company now predicts filing for a CE mark by the end of 2016, and is looking for a partner to help commercialize it in Europe.
Medtech Execs On The Move, October 2015
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Medical Device Deals Update, June-July 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced May-June 2015.
Company Information
- Industry
- Medical Devices
- Other Names / Subsidiaries
-
- Arch Biosurgery, Inc.
- Clear Nano Solutions, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice